Heterozygosity for the F508del Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Anion Channel Attenuates Influenza Severity
Author(s) -
Famke Aeffner,
Basant Abdulrahman,
Judy M. HickmanDavis,
Paul M.L. Janssen,
Amal O. Amer,
David M. Bedwell,
Eric J. Sorscher,
Ian C. Davis
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit251
Subject(s) - cystic fibrosis transmembrane conductance regulator , cystic fibrosis , mutation , regulator , loss of heterozygosity , heterozygote advantage , compound heterozygosity , ion channel , medicine , transmembrane protein , biology , conductance , cancer research , virology , genetics , chemistry , gene , genotype , allele , physics , receptor , condensed matter physics
Seasonal and pandemic influenza are significant public health concerns. Influenza stimulates respiratory epithelial Cl(-) secretion via the cystic fibrosis transmembrane conductance regulator (CFTR). The purpose of this study was to determine the contribution of this effect to influenza pathogenesis in mice with reduced CFTR activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom